Chronic Hepatitis B Virus Is Undertreated
By Lori Solomon HealthDay Reporter
FRIDAY, May 3, 2024 -- Underassessment and undertreatment of chronic hepatitis B virus (HBV) is seen globally, according to a study published online May 1 in the Journal of Hepatology.
Sahith Kudaravalli, from Stanford University in Palo Alto, California, and colleagues examined rates of evaluation and treatment in patients from the Real-world Effectiveness from the global Alliance for HBV (REAL-B) consortium. The analysis included 12,566 adult treatment-naïve patients with chronic HBV from 25 centers in nine countries.
The researchers found that 73.3 percent of patients received adequate evaluation, and among the adequately evaluated, 32.6 percent were treatment-eligible by American Association for the Study of Liver Diseases criteria. Of the treatment-eligible individuals, 83.3 percent initiated nucleos(t)ide analogues (NAs). Similar findings were seen when using European Association for the Study of the Liver criteria. When adjusting for age, sex, cirrhosis, and ethnicity plus region, female sex was associated with adequate evaluation (adjusted odds ratio, 1.13), but female treatment-eligible patients were significantly less likely to initiate NAs (adjusted odds ratio, 0.54). The lowest evaluation and treatment rates were seen among Asian patients from the West.
"Improved linkage to care with linguistically competent and culturally sensitive approaches is needed," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
High Level of Approval Observed for Polygenic Embryo Screening
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...
AI Chatbots Can Generate Quality, Empathetic, Readable Responses
FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...
Slight Decline Seen in U.S. Drug Overdose Deaths
THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.